About the Product

Description


Capofen 1gm Injection containing Capreomycin is used for the management of resistant tuberculosis infections. It helps inhibit bacterial growth and supports effective anti-tubercular treatment.

Capreomycin works as an anti-tubercular antibiotic that interferes with bacterial protein synthesis, thereby helping control Mycobacterium tuberculosis growth.

The injection is widely used in specialized infectious disease and hospital settings for multidrug-resistant tuberculosis management, leading to consistent institutional demand.

With increasing focus on advanced tuberculosis management and resistant infection control, this product offers strong business potential for retailers and distributors. Its established anti-tubercular action, critical therapeutic relevance, and steady market demand make it a reliable product for growth in the infectious disease care segment.

Some patients may experience injection site pain, nausea, dizziness, kidney function disturbances, hearing impairment, or electrolyte imbalance. Rarely, severe allergic reactions, nephrotoxicity, or ototoxicity may occur and require immediate medical attention.

Capofen 1gm Injection is indicated for multidrug-resistant tuberculosis (MDR-TB) and other resistant mycobacterial infections as part of combination antitubercular therapy. It helps reduce bacterial growth and supports long-term infection control.

This injection should be administered strictly under medical supervision by qualified healthcare professionals. Regular monitoring of kidney function, hearing ability, and electrolyte levels is recommended during treatment. Use only as part of an appropriate multidrug antitubercular regimen.

Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Capreomycin 1gm Injection in the PCD pharma franchise market?

Capreomycin 1gm Injection has specialized and high-value demand in the hospital, pulmonology, and infectious disease segment, making it a niche product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-tubercular and critical-care portfolios.

Why should medical distributors include Capreomycin 1gm Injection in their product range?

Medical distributors and agencies can benefit from institutional demand for resistant tuberculosis management under strict medical supervision. Capreomycin 1gm is a second-line injectable anti-tubercular antibiotic Commonly used in the treatment of multi-drug resistant tuberculosis (MDR-TB) and other complicated tuberculosis cases as part of combination therapy Plays an important role in specialized TB treatment protocols when first-line therapies are ineffective or unsuitable Widely utilized in TB specialty centers, pulmonology departments, and tertiary care hospitals Requires administration and monitoring by qualified healthcare professionals This strengthens a specialized anti-tubercular and infectious disease portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Capreomycin 1gm Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from institutional procurement opportunities, specialist-driven prescriptions, niche market positioning, and comparatively lower competition, along with reliable supply chain support and strong margin potential in the anti-tubercular segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for long-term business growth.